These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18830876)

  • 1. Cytotoxic activity of 4'-hydroxychalcone derivatives against Jurkat cells and their effects on mammalian DNA topoisomerase I.
    Gul HI; Cizmecioglu M; Zencir S; Gul M; Canturk P; Atalay M; Topcu Z
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):804-7. PubMed ID: 18830876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives.
    Na Y; Nam JM
    Bioorg Med Chem Lett; 2011 Jan; 21(1):211-4. PubMed ID: 21115246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-targeting pyrroloquinoline-linked butenone and chalcones: synthesis and biological evaluation.
    Dalla Via L; Gia O; Chiarelotto G; Ferlin MG
    Eur J Med Chem; 2009 Jul; 44(7):2854-61. PubMed ID: 19155103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
    Thapa P; Karki R; Thapa U; Jahng Y; Jung MJ; Nam JM; Na Y; Kwon Y; Lee ES
    Bioorg Med Chem; 2010 Jan; 18(1):377-86. PubMed ID: 19939682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays.
    Coban G; Zencir S; Zupkó I; Réthy B; Gunes HS; Topcu Z
    Eur J Med Chem; 2009 May; 44(5):2280-5. PubMed ID: 18692939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.
    Kim SH; Lee E; Baek KH; Kwon HB; Woo H; Lee ES; Kwon Y; Na Y
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3320-4. PubMed ID: 23608763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity of bis-benzimidazole derivatives on DNA topoisomerase I and HeLa, MCF7 and A431 cells.
    Alpan AS; Zencir S; Zupkó I; Coban G; Réthy B; Gunes HS; Topcu Z
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):844-9. PubMed ID: 18951286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory and gastroprotective properties of some chalcones.
    Okunrobo LO; Usifoh CO; Uwaya JO
    Acta Pol Pharm; 2006; 63(3):195-9. PubMed ID: 20085224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of synthesized 2'-oxygenated chalcone derivatives: modulation of human cell cycle phase distribution.
    Rao YK; Fang SH; Tzeng YM
    Bioorg Med Chem; 2004 May; 12(10):2679-86. PubMed ID: 15110849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.
    Cho HJ; Jung MJ; Woo S; Kim J; Lee ES; Kwon Y; Na Y
    Bioorg Med Chem; 2010 Feb; 18(3):1010-7. PubMed ID: 20093033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of 1-aryl-3-buthylamino-1-propanone hydrochlorides against Jurkat and L6 cells.
    Gul M; Mete E; Atalay M; Arik M; Gul HI
    Arzneimittelforschung; 2009; 59(7):364-9. PubMed ID: 19728564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
    Basnet A; Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jahng Y; Na Y; Cho WJ; Kwon Y; Lee CS; Lee ES
    Bioorg Med Chem Lett; 2010 Jan; 20(1):42-7. PubMed ID: 19954977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.
    Karki R; Thapa P; Kang MJ; Jeong TC; Nam JM; Kim HL; Na Y; Cho WJ; Kwon Y; Lee ES
    Bioorg Med Chem; 2010 May; 18(9):3066-77. PubMed ID: 20392646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolinyl and quinolinyl N-oxide chalcones: synthesis, antifungal and cytotoxic activities.
    de Carvalho Tavares L; Johann S; Maria de Almeida Alves T; Guerra JC; Maria de Souza-Fagundes E; Cisalpino PS; Bortoluzzi AJ; Caramori GF; de Mattos Piccoli R; Braibante HT; Braibante ME; Pizzolatti MG
    Eur J Med Chem; 2011 Sep; 46(9):4448-56. PubMed ID: 21816519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amidine analogues of melphalan: synthesis, cytotoxic activity, and DNA binding properties.
    Bielawska A; Bielawski K; Anchim T
    Arch Pharm (Weinheim); 2007 May; 340(5):251-7. PubMed ID: 17458920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of some bis Mannich bases and corresponding piperidinols on DNA topoisomerase I.
    Canturk P; Kucukoglu K; Topcu Z; Gul M; Gul HI
    Arzneimittelforschung; 2008; 58(12):686-91. PubMed ID: 19202742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicity.
    Ruchelman AL; Singh SK; Ray A; Wu X; Yang JM; Zhou N; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2004 Feb; 12(4):795-806. PubMed ID: 14759740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, topoisomerase I inhibitory activity and in vitro cytotoxicity of camptothecin derivatives bearing five-membered heterocycle containing 10-substituents.
    Zhao R; Guan LL; Oreski B; Lown JW
    Anticancer Drug Des; 1998 Mar; 13(2):145-57. PubMed ID: 9524556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
    Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.